Long-Acting Injectable Naltrexone Induction: A Randomized Trial of Outpatient Opioid Detoxification With Naltrexone Versus Buprenorphine.
about
Update on Barriers to Pharmacotherapy for Opioid Use Disorders.Long-term follow-up study of community-based patients receiving XR-NTX for opioid use disorders.A novel non-opioid protocol for medically supervised opioid withdrawal and transition to antagonist treatment.Treatment Strategies for the Opioid-Dependent Patient.The relationship between treatment accessibility and preference amongst out-of-treatment individuals who engage in non-medical prescription opioid use.Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial.Extended-release injectable naltrexone for opioid use disorder: A systematic review.Commentary: Providing technical assistance for the state targeted response for opioid use disorders: Time is of the essence.Antagonists in the medical management of opioid use disorders: Historical and existing treatment strategies.Predictors of induction onto extended-release naltrexone among unemployed heroin-dependent adults.
P2860
Q30234408-5F484237-AC31-4D37-A9E0-E8F2F5C043C6Q39192957-8CCF95D7-DD7D-451C-99FB-484FA46586DFQ43061611-5E05ED67-EDF0-49C5-8CFE-BB6D74EEFBE2Q43075998-78F5A1E5-10C0-48BC-90C9-7D1860F84B8AQ44349161-76ED9571-FDC9-4495-82EC-8D1C0466E50EQ44351156-A4C3F786-790C-491C-98FD-52411784BB62Q48111086-84F50809-04DC-4E74-A860-388D7392798DQ52316752-4F642688-61CC-4095-B395-4271D5B506BAQ52317035-540B4688-F5DB-4BAA-B3E4-BE3348D39CE1Q53621004-C9400B52-2940-4922-86F2-0E3DBA715F5B
P2860
Long-Acting Injectable Naltrexone Induction: A Randomized Trial of Outpatient Opioid Detoxification With Naltrexone Versus Buprenorphine.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Long-Acting Injectable Naltrex ...... ltrexone Versus Buprenorphine.
@en
Long-Acting Injectable Naltrex ...... ltrexone Versus Buprenorphine.
@nl
type
label
Long-Acting Injectable Naltrex ...... ltrexone Versus Buprenorphine.
@en
Long-Acting Injectable Naltrex ...... ltrexone Versus Buprenorphine.
@nl
prefLabel
Long-Acting Injectable Naltrex ...... ltrexone Versus Buprenorphine.
@en
Long-Acting Injectable Naltrex ...... ltrexone Versus Buprenorphine.
@nl
P2093
P2860
P1476
Long-Acting Injectable Naltrex ...... ltrexone Versus Buprenorphine.
@en
P2093
C Jean Choi
Edward V Nunes
Elias Dakwar
Frances R Levin
John J Mariani
Kaitlyn Mishlen
Kenneth M Carpenter
Maria Sullivan
Martina Pavlicova
P2860
P304
P356
10.1176/APPI.AJP.2016.16050548
P407
P50
P577
2017-01-10T00:00:00Z